» Articles » PMID: 31678026

Quantifying Risks and Interventions That Have Affected the Burden of Lower Respiratory Infections Among Children Younger Than 5 Years: an Analysis for the Global Burden of Disease Study 2017

Overview
Date 2019 Nov 4
PMID 31678026
Citations 78
Affiliations
Soon will be listed here.
Abstract

Background: Despite large reductions in under-5 lower respiratory infection (LRI) mortality in many locations, the pace of progress for LRIs has generally lagged behind that of other childhood infectious diseases. To better inform programmes and policies focused on preventing and treating LRIs, we assessed the contributions and patterns of risk factor attribution, intervention coverage, and sociodemographic development in 195 countries and territories by drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) LRI estimates.

Methods: We used four strategies to model LRI burden: the mortality due to LRIs was modelled using vital registration data, demographic surveillance data, and verbal autopsy data in a predictive ensemble modelling tool; the incidence of LRIs was modelled using population representative surveys, health-care utilisation data, and scientific literature in a compartmental meta-regression tool; the attribution of risk factors for LRI mortality was modelled in a counterfactual framework; and trends in LRI mortality were analysed applying changes in exposure to risk factors over time. In GBD, infectious disease mortality, including that due to LRI, is among HIV-negative individuals. We categorised locations based on their burden in 1990 to make comparisons in the changing burden between 1990 and 2017 and evaluate the relative percent change in mortality rate, incidence, and risk factor exposure to explain differences in the health loss associated with LRIs among children younger than 5 years.

Findings: In 2017, LRIs caused 808 920 deaths (95% uncertainty interval 747 286-873 591) in children younger than 5 years. Since 1990, there has been a substantial decrease in the number of deaths (from 2 337 538 to 808 920 deaths; 65·4% decrease, 61·5-68·5) and in mortality rate (from 362·7 deaths [330·1-392·0] per 100 000 children to 118·9 deaths [109·8-128·3] per 100 000 children; 67·2% decrease, 63·5-70·1). LRI incidence declined globally (32·4% decrease, 27·2-37·5). The percent change in under-5 mortality rate and incidence has varied across locations. Among the risk factors assessed in this study, those responsible for the greatest decrease in under-5 LRI mortality between 1990 and 2017 were increased coverage of vaccination against Haemophilus influenza type b (11·4% decrease, 0·0-24·5), increased pneumococcal vaccine coverage (6·3% decrease, 6·1-6·3), and reductions in household air pollution (8·4%, 6·8-9·2).

Interpretation: Our findings show that there have been substantial but uneven declines in LRI mortality among countries between 1990 and 2017. Although improvements in indicators of sociodemographic development could explain some of these trends, changes in exposure to modifiable risk factors are related to the rates of decline in LRI mortality. No single intervention would universally accelerate reductions in health loss associated with LRIs in all settings, but emphasising the most dominant risk factors, particularly in countries with high case fatality, can contribute to the reduction of preventable deaths.

Funding: Bill & Melinda Gates Foundation.

Citing Articles

Air Pollutants Associated Hospitalization in Pediatric Pneumonia: A National Database Analysis.

Sitthikarnkha P, Uppala R, Techasatian L, Saengnipanthkul S, Niamsanit S, Peansukwech U Pediatr Pulmonol. 2025; 60(2):e71009.

PMID: 39950392 PMC: 11826497. DOI: 10.1002/ppul.71009.


A 32-year trend analysis of lower respiratory infections in children under 5: insights from the global burden of disease study 2021.

Wang Y, Han R, Ding X, Chen J, Feng W, Wang C Front Public Health. 2025; 13:1483179.

PMID: 39911225 PMC: 11794078. DOI: 10.3389/fpubh.2025.1483179.


Long-term impact of 10-valent pneumococcal conjugate vaccine among children <5 years, Uganda, 2014-2021.

Wanyana M, Migisha R, King P, Bulage L, Kwesiga B, Kadobera D PLOS Glob Public Health. 2025; 5(1):e0002980.

PMID: 39761235 PMC: 11703042. DOI: 10.1371/journal.pgph.0002980.


Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024; 404(10471):2543-2583.

PMID: 39667386 PMC: 11703702. DOI: 10.1016/S0140-6736(24)01821-X.


Trends in mortality from lower respiratory infections in children under 14 years, 1990-2019: An analysis of the Global Burden of Disease Study 2019.

Xing X, Tang S, Wang W, Xiong H, Zhang T, Wang W Heliyon. 2024; 10(21):e39502.

PMID: 39559227 PMC: 11570512. DOI: 10.1016/j.heliyon.2024.e39502.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
Foreman K, Lozano R, Lopez A, Murray C . Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012; 10:1. PMC: 3315398. DOI: 10.1186/1478-7954-10-1. View

3.
Rogawski E, Platts-Mills J, Seidman J, John S, Mahfuz M, Ulak M . Use of antibiotics in children younger than two years in eight countries: a prospective cohort study. Bull World Health Organ. 2017; 95(1):49-61. PMC: 5180352. DOI: 10.2471/BLT.16.176123. View

4.
Jack D, Asante K, Wylie B, Chillrud S, Whyatt R, Ae-Ngibise K . Ghana randomized air pollution and health study (GRAPHS): study protocol for a randomized controlled trial. Trials. 2015; 16:420. PMC: 4579662. DOI: 10.1186/s13063-015-0930-8. View

5.
Theodoratou E, Johnson S, Jhass A, Madhi S, Clark A, Boschi-Pinto C . The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol. 2010; 39 Suppl 1:i172-85. PMC: 2845872. DOI: 10.1093/ije/dyq033. View